|Bid||7.00 x 2200|
|Ask||10.00 x 800|
|Day's Range||7.20 - 7.92|
|52 Week Range||3.88 - 13.51|
|Beta (5Y Monthly)||2.60|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.00|
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22. Echo Global Logistics, Inc. (NASDAQ: ECHO) surged 53.8% to $48.16 after the company agreed to be acquired by priva
Vince Holding Corp. (VNCE) delivered earnings and revenue surprises of 92.19% and 11.44%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, September 09, 2021--Vince Holding Corp. (NYSE:VNCE), a leading global contemporary group ("Vince" or the "Company"), today reported its financial results for the second quarter 2021 ended July 31, 2021.